Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 91 AL 105

Inflammatory Bridges: Interconnections Between Alzheimer's Disease and Bone Health

Li H, Wang W, Zhang L, Wang T, Liu J, Wu J, Ni Q, Sun B, Sun J.

Aging Dis. 2025 Mar 19;17(2):927-981. doi: 10.14336/AD.2025.10319.

Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease

Marco-Contelles JL, Oset-Gasque MJ.

Chem Biol Interact. 2025 May 25;413:111497. doi: 10.1016/j.cbi.2025.111497. Epub 2025 Mar 28.

New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD

Yang X, Yao K, Zhang M, Zhang W, Zu H.

Brain Res Bull. 2025 May;224:111321. doi: 10.1016/j.brainresbull.2025.111321. Epub 2025 Mar 29.

Immune modulation to treat Alzheimer's disease

Duggan MR, Morgan DG, Price BR, Rajbanshi B, Martin-Peña A, Tansey MG, Walker KA.

Mol Neurodegener. 2025 Mar 31;20(1):39. doi: 10.1186/s13024-025-00828-x.

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi R, Andrews TJ, Hicar MD.

Virology. 2025 Jun;607:110523. doi: 10.1016/j.virol.2025.110523. Epub 2025 Mar 27.

Unraveling the cGAS-STING pathway in Alzheimer's disease: A new Frontier in neuroinflammation and therapeutic strategies

Kaur A, Aran KR.

Neuroscience. 2025 May 7;573:430-441. doi: 10.1016/j.neuroscience.2025.04.001. Epub 2025 Apr 2.

Internalization of extracellular Tau oligomers in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Clin Chem. 2025;126:1-29. doi: 10.1016/bs.acc.2025.01.005. Epub 2025 Feb 12.

Reducing Alzheimer's disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection

Alami M, Morvaridzadeh M, El Khayari A, Boumezough K, El Fatimy R, Khalil A, Fulop T, Berrougui H.

Ageing Res Rev. 2025 Jun;108:102751. doi: 10.1016/j.arr.2025.102751. Epub 2025 Apr 7.

Microbial diversity and fitness in the gut-brain axis: influences on developmental risk for Alzheimer's disease

Jamerlan AM, An SSA, Hulme JP.

Gut Microbes. 2025 Dec;17(1):2486518. doi: 10.1080/19490976.2025.2486518. Epub 2025 Apr 10.

Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer's Disease-Insights from In Vivo and In Vitro Studies

Sirimaharaj N, Thiankhaw K, Chattipakorn N, Chattipakorn SC.

Mol Neurobiol. 2025 Aug;62(8):10414-10426. doi: 10.1007/s12035-025-04904-7. Epub 2025 Apr 10.

Altered Clearance and Amyloid-Related Imaging Abnormalities

Cogswell PM, Burkett BJ, Johnson DR, Pillai JJ.

Neuroimaging Clin N Am. 2025 May;35(2):267-275. doi: 10.1016/j.nic.2024.12.002. Epub 2025 Feb 19.

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha YA, Rampes S, Tromp S, Boyanova ST, Fleckney A, Fidanboylu M, Thomas SA.

Pharmacol Rev. 2025 May;77(3):100052. doi: 10.1016/j.pharmr.2025.100052. Epub 2025 Mar 13.

Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease

Saadh MJ, Muhammad FA, Alazzawi TS, Fahdil AA, Athab ZH, Tuxtayev J, Alsaikhan F, Farhood B.

Mol Neurobiol. 2025 Aug;62(8):10577-10613. doi: 10.1007/s12035-025-04833-5. Epub 2025 Apr 12.

Physical activity in Alzheimer's disease prevention: Sex differences and the roles of BDNF and irisin

Barros-Aragão FGQ, Januszkiewicz E, Hunter T, Lyra E Silva NM, De Felice FG.

Front Neuroendocrinol. 2025 Apr;77:101189. doi: 10.1016/j.yfrne.2025.101189. Epub 2025 Apr 12.

Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer's Disease

Bogadi S, Bhaskaran M, Ravichandran V, Nesamony J, Chelliah S, Kuppusamy G, Prakash GM, Karri VVSR, Mallick S, Farahim F, Ali T, Babu DR, Subramaniyan V.

Mol Neurobiol. 2025 Aug;62(8):10915-10934. doi: 10.1007/s12035-025-04917-2. Epub 2025 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias